Melissa Yeager
Private Equity Investor bij Accelerator Services Corp
Profiel
Melissa A.
Yeager founded Cardeas Pharma Corp.
in 2011, where she worked as Chief Operating Officer from 2011 to 2016.
Ms. Yeager also currently works at Accelerator Services Corp, as Operating Partner from 2020.
Ms. Yeager also formerly worked at PathoGenesis Corp, as Senior Director-Regulatory Affairs, ALZA Corp., as Senior Regulatory Affairs Associate, Gilead Sciences, Inc., as Vice President-Regulatory Affairs from 2001 to 2009, Corus Pharma, Inc., as VP-Regulatory Affairs & Quality Assurance from 2001 to 2006, Seattle Biomedical Research Institute, as Trustee, Lundbeck Seattle BioPharmaceuticals, Inc., as Senior Vice President-Regulatory Affairs, Lundbeck Seattle BioPharmaceuticals, Inc., as Senior Vice President from 2018 to 2019, Jaguar Health, Inc., as Senior VP-Regulatory Affairs & Quality Assurance, and Breath Therapeutics, Inc., as Chief Regulatory Officer from 2017 to 2018.
Ms. Yeager received her undergraduate degree in 1977 from Stanford University and graduate degree in 1985 from Santa Clara University.
Actieve functies van Melissa Yeager
Bedrijven | Functie | Begin |
---|---|---|
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 01-08-2020 |
Eerdere bekende functies van Melissa Yeager
Bedrijven | Functie | Einde |
---|---|---|
ALDER BIOPHARMACEUTICALS, INC. | Private Equity Investor | 02-01-2019 |
Breath Therapeutics, Inc. | Corporate Officer/Principal | 30-08-2018 |
Cardeas Pharma Corp.
Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Founder | 01-07-2016 |
GILEAD SCIENCES, INC. | General Counsel | 01-01-2009 |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | General Counsel | 01-01-2006 |
Opleiding van Melissa Yeager
Stanford University | Undergraduate Degree |
Santa Clara University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
JAGUAR HEALTH, INC. | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a private company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Health Technology |
Cardeas Pharma Corp.
Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Health Technology |
Seattle Biomedical Research Institute
Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Commercial Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Breath Therapeutics, Inc. |